| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | SVP Clinical Development
2 companies
Cadavid Diego is a Chief Medical Officer at X4 Pharmaceuticals, Inc with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $677K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | XFOR X4 Pharmaceuticals, Inc | Chief Medical Officer | Sell | 928 | $0.00 | - | -11.5% | -33.3% | -37.8% | |
| Jul 1, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sell | 1,071 | $18.30 | $19,599.30 | -1.6% | - | - | |
| Jun 25, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sale+OE | 1,459 | $22.00 | $32,098.00 | -2.1% | - | - | |
| Jun 10, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sale+OE | 401 | $22.00 | $8,822.00 | -0.6% | - | - | |
| Jun 5, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sale+OE | 677 | $20.14 | $13,632.03 | -0.5% | - | - | |
| Jun 3, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sale+OE | 383 | $20.16 | $7,719.59 | -0.3% | - | - | |
| May 29, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sale+OE | 800 | $20.01 | $16,007.00 | -0.6% | - | - | |
| May 12, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sale+OE | 1,860 | $18.00 | $33,480.00 | -2.7% | - | - | |
| Mar 2, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sell | 2,143 | $17.38 | $37,254.78 | -1.6% | - | - | |
| Feb 3, 2020 | FULC Fulcrum Therapeutics, Inc. | SVP Clinical Development | Sell | 2,143 | $17.33 | $37,141.83 | -3.0% | - | - |